oral JH2-binding Tyk2 inhibitor
Ph. I in psoriasis complete
backup candidate to BMS-986165 for psoriasis
J. Med. Chem., Dec. 28, 2020
Bristol-Myers Squibb, Princeton, NJ
BMS-986202
1 min read
Bristol Myers Squibb (BMS) oral JH2-domain binding Tyk2 kinase inhibitor
Search By Structure
- OI338
- PF07059013
- AZD0364
- PF-06843195
- TP0586352
- AZD4573
- “compound 42”
- “compound 12”
- BMS-986202
- pamiparib
- linrodostat
- SAR439859
- ACT-1004-1239
- “compound 1”
Molecules of the Month
2023
2022
2021
2020